Fed. Circ. Clears Boston Scientific In $200M Stent IP Case

Law360, New York (September 29, 2017, 6:51 PM EDT) -- The Federal Circuit on Friday upheld a decision clearing Boston Scientific Corp. in a cardiologist’s contract suit seeking more than $200 million in royalties on his stent patents, concluding that the company is shielded from liability by the rarely invoked ensnarement defense.

The appeals court ruled that Judge Virginia Phillips of the Central District of California correctly held in 2015 that Boston Scientific’s Express coronary stent is not covered by Dr. David Jang's patent, so the company need not pay royalties.

The judge’s ruling came after...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Jang v. Boston Scientific Corporation


Case Number

16-1275

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

December 2, 2015

Law Firms

Companies

Patents

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.